For scientists pursuing careers in embedded pragmatic clinical trials for people living with Alzheimer’s disease and Alzheimer’s disease-related dementias (AD/ADRD) and their care partners.
Informational Webinars
Tuesday, January 19, 2021 at 2:00 pm ET: Registration closed.
Wednesday, February 3, 2021 at 3:00 pm ET: Registration closed.
Application Period Opens
January 18, 2021
Proposals Due
April 2, 2021 @ 5pm ET
Read full Request for Applications (RFA)
The NIA IMPACT Collaboratory (U54AG063546) is pleased to announce the request for applications for the 2021 IMPACT Career Development Award. We encourage applications from early-stage investigators interested in a research career that includes conducting embedded pragmatic clinical trials (ePCTs) of non-pharmacologic interventions within healthcare systems (HCS) for people living with Alzheimer’s disease (AD) and AD-related dementias (ADRD) and their care partners. The recent $300 million increase in National Institutes of Health funding for AD/ADRD research, reflects the urgency and opportunities for investigators focused in this area.
Conducting ePCTs in AD/ADRD within HCS requires unique research skills, yet the field is relatively nascent. The number of investigators capable of rigorously designing and executing ePCTs in partnership with HCS and other key stakeholders remains limited, and those that have intersecting expertise in AD/ADRD populations are even fewer. Thus, a critical objective of the IMPACT Collaboratory is to build the nation’s capacity to conduct impactful ePCTs in AD/ADRD by training a workforce of investigators prepared to carry on this work well into the future.
The IMPACT Collaboratory funds up to four career development awards (CDAs) annually. These CDAs seek to support the development of early-stage MD, PhD, or equivalent researchers who seek careers conducting ePCTs for people living with AD/ADRD and their care partners. The IMPACT Collaboratory prioritizes applications that address dementia care for people of all backgrounds and promote health equity. CDAs are funded for two years. Each award will provide $100,000 annually in direct costs with an indirect cost rate capped at 8%. Awardees are required to devote a minimum of 75% effort toward the goals of the award.
A set of frequently asked questions (FAQ) regarding this award is available at https://impactcollaboratory.org/CDA-grant-faq/. Additionally, please email IMPACTcollaboratory@hsl.harvard.edu with any questions.